Literature DB >> 24720796

Unexpected complication of intralesional injection of recombinant human epidermal growth factor: diabetic foot osteomyelitis.

Omer Ersen1, Kemal Kara2, Ali Memis3, Mesut Mutluoglu4, Hakan Ay4.   

Abstract

Entities:  

Year:  2014        PMID： 24720796      PMCID： PMC7949740          DOI： 10.1111/iwj.12264

Source DB:  PubMed          Journal:  Int Wound J        ISSN： 1742-4801            Impact factor:   3.315


× No keyword cloud information.
  3 in total

1.  Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.

Authors:  José I Fernández-Montequín; Blas Y Betancourt; Gisselle Leyva-Gonzalez; Ernesto L Mola; Katia Galán-Naranjo; Mayte Ramírez-Navas; Sergio Bermúdez-Rojas; Felix Rosales; Elizeth García-Iglesias; Jorge Berlanga-Acosta; Ricardo Silva-Rodriguez; Marianela Garcia-Siverio; Luis H Martinez
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

2.  Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study.

Authors:  José I Fernández-Montequín; Carmen M Valenzuela-Silva; Odalys González Díaz; William Savigne; Natasha Sancho-Soutelo; Fidel Rivero-Fernández; Pablo Sánchez-Penton; Lourdes Morejón-Vega; Heriberto Artaza-Sanz; Arístides García-Herrera; Cecilio González-Benavides; Carlos M Hernández-Cañete; Alberto Vázquez-Proenza; Jorge Berlanga-Acosta; Pedro A López-Saura
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

3.  Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.

Authors:  José I Fernández-Montequín; Ena Infante-Cristiá; Carmen Valenzuela-Silva; Neobalis Franco-Pérez; William Savigne-Gutierrez; Heriberto Artaza-Sanz; Lourdes Morejón-Vega; Cecilio González-Benavides; Osvaldo Eliseo-Musenden; Elizeth García-Iglesias; Jorge Berlanga-Acosta; Ricardo Silva-Rodríguez; Blas Y Betancourt; Pedro A López-Saura
Journal:  Int Wound J       Date:  2007-10-22       Impact factor: 3.315
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.